NPCE
NeuroPace Inc
- Latest sale
- $399k
- Dec 15 · Unusual
- Form 4 sales
- 27
- On record
- Form 144 notices
- 4
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleNo planOct 22 2024
Sold 4,082 shares at $6.09 ($25k)
Kck Ltd., 10% owner
No 10b5-1 planSold 0.1% of holdings ($33.5M position)5.5M shares left0.3x usual sizeFiling
- 2 Form 4 saleUnusualOct 25 +3 days
Sold 224,138 shares at $5.45 ($1.2M)
Kck Ltd., 10% owner
No 10b5-1 planSold 4.1% of holdings ($29.9M position)5.3M shares left16.4x usual sizeFiling
- 3 Form 4 saleRoutineJan 24 +91 days
Sold 3,200 shares at $15.01 ($48k)
Morrell Martha, CHIEF MEDICAL OFFICER
10b5-1 planSold 3.5% of holdings ($1.4M position)87,062 shares left0.3x usual sizeFiling
- 4 Form 4 saleRoutineJan 30 +6 days
Sold 300 shares at $15.00 ($5k)
Morrell Martha, CHIEF MEDICAL OFFICER
10b5-1 planSold 0.3% of holdings ($1.3M position)86,762 shares left0x usual sizeFiling
- 5 Form 4 saleUnusualFeb 20 +21 days
Sold 5.3M shares at $9.40 ($49.5M)
Kck Ltd., 10% owner
No 10b5-1 planSold 100% of holdings ($49.5M position)0 shares left326x usual sizeFiling
- 6 Form 4 saleUnusualFeb 21 +1 day
Sold 78,334 shares at $13.72 ($1.1M)
Morrell Martha, CHIEF MEDICAL OFFICER
No 10b5-1 planSold 48.9% of holdings ($2.2M position)81,993 shares left11x usual sizeFiling
- 7 Form 4 saleUnusualMay 14 +82 days
Sold 168,136 shares at $15.85 ($2.7M)
Orbimed Advisors LLC, 10% owner
No 10b5-1 planSold 4.9% of holdings ($54M position)3.2M shares left5.8x usual sizeFiling
- 8 Form 4 saleUnusualDec 15 +215 days
Sold 25,000 shares at $15.97 ($399k)
Morrell Martha, CHIEF MEDICAL OFFICER
No 10b5-1 planSold 33.3% of holdings ($1.2M position)49,964 shares left3x usual sizeFiling
Every transaction
Loading transactions…
Sales, notices and lockups (31)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | Morrell Martha | CHIEF MEDICAL OFFICER | Form 4 sale | 25,000 | $399k | 33.3% | Unusual | SEC |
| May 14, 2025 | Orbimed Advisors LLC | 10% owner | Form 4 sale | 168,136 | $2.7M | 4.9% | Unusual | SEC |
| Feb 21, 2025 | Morrell Martha | CHIEF MEDICAL OFFICER | Form 4 sale | 78,334 | $1.1M | 48.9% | Unusual | SEC |
| Feb 20, 2025 | Kck Ltd. | 10% owner | Form 4 sale | 5.3M | $49.5M | 100.0% | Unusual | SEC |
| Jan 30, 2025 | Morrell Martha | CHIEF MEDICAL OFFICER | Form 4 sale | 300 | $5k | 0.3% | Routine | SEC |
| Jan 24, 2025 | Morrell Martha | CHIEF MEDICAL OFFICER | Form 4 sale | 3,200 | $48k | 3.5% | Routine | SEC |
| Oct 25, 2024 | Kck Ltd. | 10% owner | Form 4 sale | 224,138 | $1.2M | 4.1% | Unusual | SEC |
| Oct 22, 2024 | Kck Ltd. | 10% owner | Form 4 sale | 4,082 | $25k | 0.1% | No plan | SEC |
| Oct 21, 2024 | Kck Ltd. | 10% owner | Form 4 sale | 8,598 | $53k | 0.2% | No plan | SEC |
| Oct 17, 2024 | Kck Ltd. | 10% owner | Form 4 sale | 46,426 | $303k | 0.8% | No plan | SEC |
| Oct 2, 2024 | Kck Ltd. | 10% owner | Form 4 sale | 39,684 | $275k | 0.7% | No plan | SEC |
| May 3, 2024 | Orbimed Advisors LLC | 10% owner | Form 4 sale | 29,206 | $409k | 0.9% | No plan | SEC |
| Apr 24, 2024 | Orbimed Advisors LLC | 10% owner | Form 4 sale | 1,781 | $25k | 0.1% | No plan | SEC |
| Apr 23, 2024 | Orbimed Advisors LLC | 10% owner | Form 4 sale | 64,653 | $913k | 1.8% | No plan | SEC |
| Apr 18, 2024 | OrbiMed Capital GP VI LLC | 10% owner | Form 4 sale | 16,992 | $238k | 0.5% | No plan | SEC |
| Apr 12, 2024 | OrbiMed Capital GP VI LLC | 10% owner | Form 4 sale | 485,000 | $7M | 12.1% | No plan | SEC |
| Feb 5, 2024 | Morrell Martha | Chief Medical Officer | Form 4 sale | 17,589 | $265k | 18.4% | No plan | SEC |
| Feb 1, 2024 | Morrell Martha | Chief Medical Officer | Form 4 sale | 13,848 | $209k | 12.7% | No plan | SEC |
| Jan 25, 2024 | Morrell Martha | Chief Medical Officer | Form 4 sale | 828 | $12k | 0.8% | No plan | SEC |
| Dec 27, 2023 | Morrell Martha | Chief Medical Officer | Form 4 sale | 13,402 | $136k | 10.9% | No plan | SEC |
| Dec 20, 2023 | Morrell Martha | Chief Medical Officer | Form 4 sale | 2,730 | $28k | 2.2% | No plan | SEC |
| Dec 20, 2023 | Morrell Martha | Chief Medical Officer | Form 144 notice | 48,397 | $483k | Notice | SEC | |
| Dec 6, 2023 | Morrell Martha | Chief Medical Officer | Form 4 sale | 11,005 | $90k | 8.0% | No plan | SEC |
| Dec 6, 2023 | Morrell Martha | Affiliate | Form 144 notice | 11,005 | $90k | Notice | SEC | |
| Dec 1, 2023 | Kck Ltd. | 10% owner | Form 4 sale | 16,167 | $142k | 0.3% | No plan | SEC |
| Nov 29, 2023 | Kck Ltd. | Shareholder | Form 144 notice | 262,836 | $2.3M | Notice | SEC | |
| Nov 28, 2023 | Kck Ltd. | 10% owner | Form 4 sale | 11,171 | $99k | 0.2% | No plan | SEC |
| Oct 3, 2023 | OrbiMed Capital GP VI LLC | 10% owner | Form 4 sale | 8,314 | $75k | 0.2% | No plan | SEC |
| Oct 2, 2023 | Orbimed Advisors LLC | Shareholder | Form 144 notice | 288,100 | $2.6M | Notice | SEC | |
| Jun 8, 2022 | Ridley Irina | General Counsel and Secretary | Form 4 sale | 2,500 | $14k | 3.9% | Plan not stated | SEC |
| Feb 28, 2022 | Ridley Irina | General Counsel and Secretary | Form 4 sale | 1,470 | $11k | 18.1% | Plan not stated | SEC |